Covered recipient · General Payments record
SHELBI S RAMON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,274.93
- Reported across 76 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $557.17 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $143.04 | 11 |
| Amgen Inc. | $78.00 | 4 |
| Lilly USA, LLC | $54.82 | 3 |
| PFIZER INC. | $48.83 | 3 |
| UCB, Inc. | $33.30 | 2 |
| ABBVIE INC. | $24.79 | 1 |
| Lundbeck LLC | $24.23 | 1 |
| Alkermes, Inc. | $23.25 | 1 |
| Antares Pharma, Inc. | $23.08 | 1 |
| Acerta Pharma LLC | $19.13 | 1 |
| Astellas Pharma US Inc | $19.00 | 1 |
| Xeris Pharmaceuticals, Inc. | $18.68 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.16 | 1 |
| GlaxoSmithKline, LLC. | $15.92 | 1 |
| Janssen Pharmaceuticals, Inc | $14.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.79 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108057323 | CMS |
| Alkermes, Inc. | $23.25 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120578281 | CMS |
| Amgen Inc. | $19.85 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117662043 | CMS |
| Amgen Inc. | $18.21 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117360246 | CMS |
| Amgen Inc. | $18.61 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117662045 | CMS |
| Amgen Inc. | $21.33 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117360248 | CMS |
| Antares Pharma, Inc. | $23.08 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146519907 | CMS |
| Astellas Pharma US Inc | $19.00 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139466966 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.13 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104638493 | CMS |
| GlaxoSmithKline, LLC. | $15.92 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116495770 | CMS |
| Janssen Pharmaceuticals, Inc | $14.94 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078048476 | CMS |
| Lilly USA, LLC | $20.61 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135953097 | CMS |
| Lilly USA, LLC | $16.87 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135953099 | CMS |
| Lilly USA, LLC | $17.34 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135889008 | CMS |
| Lundbeck LLC | $24.23 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146079032 | CMS |
| Novo Nordisk Inc | $8.54 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100352916 | CMS |
| Novo Nordisk Inc | $18.45 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100425173 | CMS |
| Novo Nordisk Inc | $14.70 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100245763 | CMS |
| Novo Nordisk Inc | $8.65 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100294158 | CMS |
| Novo Nordisk Inc | $8.77 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100638148 | CMS |
| Novo Nordisk Inc | $16.35 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100592124 | CMS |
| Novo Nordisk Inc | $20.05 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100605010 | CMS |
| Novo Nordisk Inc | $8.05 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100355876 | CMS |
| Novo Nordisk Inc | $19.26 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100457050 | CMS |
| Novo Nordisk Inc | $19.12 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100439331 | CMS |
| Novo Nordisk Inc | $1.10 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100463844 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.16 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119167946 | CMS |
| PFIZER INC. | $16.70 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130967380 | CMS |
| PFIZER INC. | $16.47 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131480417 | CMS |
| PFIZER INC. | $15.66 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132104962 | CMS |
| UCB, Inc. | $19.24 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143422467 | CMS |
| UCB, Inc. | $14.06 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143422472 | CMS |
| Xeris Pharmaceuticals, Inc. | $18.68 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144638702 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.